Alar Pharmaceuticals Inc · TPEX:6785

Alar Pharmaceuticals Inc financial statements

Alar Pharmaceuticals Inc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020
Revenue2.75M5.82M469.3M800.0K0600.0K
Cost of revenue613.0K2.03M0
Gross profit2.14M3.79M469.3M800.0K600.0K
Research and development156.5M57.3M56.7M34.2M81.9M160.3M
Selling, general and administrative13.4M14.4M27.0M13.1M11.4M11.0M
Operating income-167.8M-67.9M391.2M-32.5M-64.2M-142.8M
Depreciation and amortization4.87M3.88M3.35M3.21M3.36M2.84M
EBITDA-162.9M-64.1M394.5M-29.3M-60.9M-139.9M
Interest expense81.0K27.0K63.0K22.0K21.0K33.0K
Income before tax-79.0M37.0M391.1M-32.5M-64.2M-142.8M
Income tax8.49M-12.7M
Net income-79.7M18.2M382.6M-19.9M-64.2M-142.8M
Earnings per share, basic-1.190.276.71-0.35-1.13-2.86

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents1.79B1.41B739.5M455.4M519.1M561.0M
Short-term investments502.9M1.03B156.5M30.9M22.7M128.5M
Receivables0840.0K0
Current assets2.35B2.44B903.0M497.6M528.7M591.4M128.5M
Total assets2.49B2.56B973.2M522.6M539.9M604.0M
Accounts payable145.0K
Current liabilities74.5M55.1M74.8M5.37M4.46M4.13M145.0K
Total debt1.41M2.69M949.0K1.52M
Total liabilities84.3M64.3M76.1M8.10M5.54M5.37M145.0K
Shareholders' equity2.40B2.49B897.1M514.5M534.4M598.6M
Shares outstanding66.8M66.8M57.1M57.0M57.0M49.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations-171.0M-75.3M403.6M-32.9M-63.5M-141.9M
Capital spending-2.87M-1.23M-6.34M-1.14M-1.58M-385.0K
Free cash flow-173.9M-76.5M397.2M-34.1M-65.0M-142.3M
Cash from financing-1.28M-929.0K-932.0K549.1M
Dividends paid-16.7M-100.2M
Change in cash387.7M666.4M284.1M-63.7M-41.9M511.5M